Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5672_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
10.10.2026
Размер:
10 Мб
Скачать
☆
394
Metals in Medicine, Volume 2
       -
nicity , high permeability , minimal cytotoxicity, and excellent stability. Green

       
        -
tion. Biosensor and imaging systems using chemically and environmentally

and increasing survival rates. Overall, Au-NPs hold great promise in cancer
research, therapy, and diagnosis.
13.1 INTRODUCTION
        
     
     
      
       
process. Despite huge progress in cancer research gold nanoparticles

      -

  -
able tumors can be surgically removed. Chemotherapeutic medications only

     
has a negative impact on healthy tissues that are in its path. Given the
       


research topic.
1
       
nanomaterials, that exhibit photonic, electrical, catalytic, and medicinal
        


2
NPs exhibit

        -
        

https://t.me/med1917
Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
395
systems.
3

             
-6
M
       



        


      


          

     



higher absorption through receptor-mediated endocytosis, a longer circula-
     


imaging.
4

       






 
5






        
  

https://t.me/med1917
396
Metals in Medicine, Volume 2
  
-
spheres, nanorods, nanocubes, nanobranches, and nanobipyramids. On the

6
13.2 METHODS FOR THE GOLD NANOPARTICLES SYNTHESIS


       
  
techniques. In this method, tannic acid, citrate, and ascorbic acid are used as
mild reducing agents to decrease Au





7

      -

       
AuCl
4

  
4
   
  





 -
    
https://t.me/med1917
Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
397

by reducing gold salts using a potential reducing substance, such as sodium

       
    
-
   
be changed.
8



       


           
attention as an environmentally benign and green technique. In biological


    


Biomolecules such as carbohydrates, lipids, nucleic acids, or proteins

        
   
hydroxyl and carbonyl that can convert Au

  

        
using this technique.
9
https://t.me/med1917
398
Metals in Medicine, Volume 2

       
       
  
        


10,11
TABLE 13.1      
Gold NPs.
12
Plant/plant part Size of Au-NP
Magnolia kobus
5–300 nm
Diopyros kaki
5–300 nm
Prunus domestica
14–26 nm
Sapindas mukorossi
9–19 nm
Coleus amboinicus Lour.
9.05–31.95 nm
Abelmoschus esculentus
45–75 nm
Zingiber officinale
5–15 nm
Rosa hybrid
10 nm
Cicer arietinum

Nyctanthes arbortristis
19.8 nm
Gnidia glauca
50–150 nm
Cassia auriculata
15–25 nm


-



      

13

 
14
.
        
https://t.me/med1917
Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
399
and biomedical research and demonstrated good catalytic, antimicrobial,
 

   
Verticillium sp. and Fusarium oxysporum

     


15
       

    
      Musa acuminata

16
13.3 PASSIVE TARGETING STRATEGIES WITH AU-NPS







1. Nanometric size: 
         
        

       


      

     

       
  
        

https://t.me/med1917
400
Metals in Medicine, Volume 2

primary tumors in vivo.
2. Nanocarrier shape and elasticity: -


to last longer than tougher NPs (3000 kPa). Overall, the accumula-

 

-
riers, and as a result, it must be tailored to each tumor type and stage

17
3. Charge: 
systems are removed quickly by the phagocyte system. So, it is



  
    


polymer chain evolves a mushroom-like spherical shape at this

-





-
 


4. Tumor microvasculature: 
  
3
       
-
      

https://t.me/med1917
Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
401


       -
     

     
or damaged. Macromolecular medicines accumulate in cancerous


    
enhance the EPR and improve drug targeting to the malignant tissue,
several communicators have been studied.
18

-


       
delivery vehicles have been approved by the US Food and Drug Administra-

system Doxil® (approved in 1995), the paclitaxel-albumin-based NP-delivery
system Abraxane® (approved in 2005), and the polymer Genexol-PM®
(approved in South Korea in 2007). micellar delivery vehicle.
     -




          


      

         

https://t.me/med1917
402
Metals in Medicine, Volume 2
 
targets such as the nucleus and mitochondria, can be targeted by receptor-
        

         


       
         

19

        


-
bodies, hormones, lectins, aptamers, and saccharides are among the ligands

20
Nanorods demonstrate persistent
-


13.4 APPLICATIONS OF GOLD NANOPARTICLES (AU-NPS)

    

-





 
       
-

1. Delivery vehicles (pharmaceutical drugs, gene, and protein delivery)

       
https://t.me/med1917
Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
403



       -
       
      

      





     
      
  -
  

          


11
       

a. Doxorubicin: Doxorubicin embedded in Au-NP, caused the
 -

21
Additionally , it


oxygen consumption, and the PPAR gamma 1-alpha expression.





      
-

Forkhead box M1. Nontargeted cells and Chinese hamster ovary
https://t.me/med1917